Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kuss

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|June 20, 2020
The upside of being a digital pharma playerAlexander Schuhmacher, Alexander Gatto, Markus Hinder, et al.
Drug Discovery Today|May 9, 2021
Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligenceAlexander Schuhmacher, Alexander Gatto, Michael Kuss, et al.
Journal of the American Podiatric Medical Association|June 5, 2012
Topical application of a gentamicin-collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trialBenjamin A Lipsky, Michael Kuss, Michael Edmonds, et al.
Journal of Pain Research|November 16, 2012
A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl(®)) with the ON-Q PainBuster(®) Post-op Pain Relief System following open gynecological surgerySusan L Cusack, Harold S Minkowitz, Michael Kuss, et al.
Drug Discovery Today|May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysisAlexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Journal of Pain Research|July 14, 2012
Clinical evaluation of XaraColl(®), a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studiesSusan L Cusack, Mark Jaros, Michael Kuss, et al.
Pain|December 20, 2015
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute painEugene R Viscusi, Lynn Webster, Michael Kuss, et al.
Science Advances|March 6, 2018
Einstein@Home discovers a radio-quiet gamma-ray millisecond pulsarColin J Clark, Holger J Pletsch, Jason Wu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|June 20, 2020
The upside of being a digital pharma playerAlexander Schuhmacher, Alexander Gatto, Markus Hinder, et al.
Drug Discovery Today|May 9, 2021
Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligenceAlexander Schuhmacher, Alexander Gatto, Michael Kuss, et al.
Journal of the American Podiatric Medical Association|June 5, 2012
Topical application of a gentamicin-collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trialBenjamin A Lipsky, Michael Kuss, Michael Edmonds, et al.
Journal of Pain Research|November 16, 2012
A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl(®)) with the ON-Q PainBuster(®) Post-op Pain Relief System following open gynecological surgerySusan L Cusack, Harold S Minkowitz, Michael Kuss, et al.
Drug Discovery Today|May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysisAlexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Journal of Pain Research|July 14, 2012
Clinical evaluation of XaraColl(®), a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studiesSusan L Cusack, Mark Jaros, Michael Kuss, et al.
Pain|December 20, 2015
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute painEugene R Viscusi, Lynn Webster, Michael Kuss, et al.
Science Advances|March 6, 2018
Einstein@Home discovers a radio-quiet gamma-ray millisecond pulsarColin J Clark, Holger J Pletsch, Jason Wu, et al.
Pageof 1